Posttraumatic Stress Disorder: Genomic Approaches through the Psychiatric Genomic Consortium Initiative
Received Date: Jul 01, 2024 / Published Date: Jul 30, 2024
Abstract
Posttraumatic Stress Disorder (PTSD) is a debilitating condition arising after exposure to traumatic events, characterized by symptoms such as intrusive memories, hyper arousal, and avoidance. Despite its significant impact on mental health, the genetic underpinnings of PTSD remain partially understood. This article reviews recent advancements in the genomic study of PTSD, focusing on the contributions of the Psychiatric Genomic Consortium (PGC). We discuss key findings from genomic studies, the role of genetic variation in PTSD susceptibility, and future directions for research. Through an analysis of the PGC's contributions, this review aims to highlight the potential for genomic approaches to enhance understanding and treatment of PTSD.
Citation: Julia H (2024) Posttraumatic Stress Disorder: Genomic Approaches through the Psychiatric Genomic Consortium Initiative. J Health Care Prev, 7: 272.
Copyright: © 2024 Julia H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Usage
- Total views: 128
- [From(publication date): 0-2024 - Feb 04, 2025]
- Breakdown by view type
- HTML page views: 98
- PDF downloads: 30
